Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy

Journal of Clinical Oncology

Volumn 4, Issue 11, 1986, Pages 1604-1614

  O'Connell, J P ^a   Kris, M G ^a   Gralla, R J ^a   Groshen, S ^b   Trust, A ^b   Fiore, J J ^b   Kelsen, D P ^b   Heelan, R T ^b   Golbey, R B ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MITOMYCIN; VINBLASTINE; VINCA ALKALOID; VINDESINE;

CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; DRUG EFFICACY; EPIDEMIOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY SYSTEM; THERAPY;

EID: 0023031031     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1986.4.11.1604     Document Type: Article

References (0)